Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-007829-40Phase 4Completed
Phase 4, randomised, open-label trial in hematoma and Subcutaneous Hemorrhage comparing Clarema arm with Hirudoid arm (2 arms). Primary endpoint: Primary efficacy endpoint. Started Mar 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-007829-40.